Results 181 to 190 of about 11,748,761 (306)
Correction to: Enhanced laser-induced PEDOT-based hydrogels for highly conductive bioelectronics. [PDF]
Zhou H +14 more
europepmc +1 more source
COMP–PMEPA1 axis promotes epithelial‐to‐mesenchymal transition in breast cancer cells
This study reveals that cartilage oligomeric matrix protein (COMP) promotes epithelial‐to‐mesenchymal transition (EMT) in breast cancer. We identify PMEPA1 (protein TMEPAI) as a novel COMP‐binding partner that mediates EMT via binding to the TSP domains of COMP, establishing the COMP–PMEPA1 axis as a key EMT driver in breast cancer.
Konstantinos S. Papadakos +6 more
wiley +1 more source
Retraction Note: Enhancing blockchain transaction classification with ensemble learning approaches. [PDF]
Panigrahi A +7 more
europepmc +1 more source
Towards Industry 4.0: Gap Analysis between Current Automotive MES and\n Industry Standards using Model-Based Requirement Engineering [PDF]
Manoj Kannan Soundarapandian +6 more
openalex +1 more source
Pre‐analytical handling critically determines liquid biopsy performance. This study defines practical best‐practice conditions for cell‐free DNA (cfDNA) and extracellular vesicle–derived DNA (evDNA), showing how processing time, storage conditions, tube type, and plasma input volume affect DNA integrity and mutation detection.
Jonas Dohmen +11 more
wiley +1 more source
Exosome-based vaccines in cancer immunotherapy: antitumor mechanisms, engineering strategies, and challenges. [PDF]
Zhou H, Shi Y, Wang Y, Bai G.
europepmc +1 more source
Loss of the miR‐214/199a cluster is associated with recurrence in ovarian cancer. Engineered small extracellular vesicles (m214‐sEVs) elevate miR‐214‐3p/miR‐199a‐5p in tumor cells, suppress β‐catenin, TLR4, and YKT6 signaling, reprogram tumor‐derived sEV cargo, reduce chemoresistance and migration, and enhance carboplatin efficacy and survival in ...
Weida Wang +12 more
wiley +1 more source
Engineering Ethics Interventions and Assessments: A Systematic Literature Review. [PDF]
Venkata Krishnan V +5 more
europepmc +1 more source
Cytarabine is a key therapy for acute myeloid leukaemia (AML), but its efficacy is limited by the dNTPase SAMHD1, which hydrolyses its active metabolite. Screening nucleotide biosynthesis inhibitors revealed that IMPDH inhibitors selectively sensitise SAMHD1‐proficient AML cells to cytarabine.
Miriam Yagüe‐Capilla +9 more
wiley +1 more source
Engineering with macromolecules: from small to large
Ulrich S. Schubert
openalex +1 more source

